Mobile

A double-blind, randomized, placebo-controlled, multi-center, Clinical Trial of ofatumumab, a fully human monoclonal anti-CD20 antibody in patients with moderate to severe stage Chronic Obstructive Pu...

Update Il y a 4 ans
Reference: EUCTR2006-003184-31

A double-blind, randomized, placebo-controlled, multi-center, Clinical Trial of ofatumumab, a fully human monoclonal anti-CD20 antibody in patients with moderate to severe stage Chronic Obstructive Pulmonary Disease

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To evaluate efficacy of ofatumumab in decreasing inflammation in COPD assessed by bronchial biopsies.

Inclusion criteria

  • Moderate to severe stage of Chronic Obstructive Pulmonary Disease (COPD)

Links